Healthcare

Urgent call to shape equitable future through collaboration

SINGAPORE (July 1): What if we could build a global economy that runs on neither self-interest nor altruism? With climate change and inequality the greatest threats to humanity in the years to come, urgent action and collaboration are needed to construct an equitable and sustainable future. The way to get there could lie in the experience of the war-torn region of Mindanao in the Philippines.

Urgent call to shape equitable future through collaboration

SINGAPORE (July 1): What if we could build a global economy that runs on neither self-interest nor altruism? With climate change and inequality the greatest threats to humanity in the years to come, urgent action and collaboration are needed to construct an equitable and sustainable future. The way to get there could lie in the experience of the war-torn region of Mindanao in the Philippines.

Categories: 

Osteopore has 'secret recipe' to regrow bones

Homegrown medtech firm taps unique technology to capture multi-billion dollar bone regenerating market

Categories: 

Rising medical costs in Singapore drive innovation in employer-sponsored health plans: Mercer Marsh Benefits

SINGAPORE (June 10): Singapore’s medical trend rate of 10% outpaced economic inflation 10-fold in 2018, and is expected to rise by 0.1% in 2019, according to Mercer Marsh Benefits (MMB) 2019 Trends Around the World report.

Insurers are also predicting further increases in 2020.

As the cost of health benefit programmes continues to rise in Singapore, employers have the opportunity to contain cost through smarter plan design and employee access to quality-focused healthcare.

UOB Venture Management launching second Asia impact fund in 2H

SINGAPORE (June 10): UOB Venture Management (UOBVM) says it intends to roll out its second impact fund, the second series of the Asia Impact Investment Fund (AIIF II), to global institutional and accredited investors in 2H19.

Focused on Asia, the AIIF II will be a double bottom-line fund that aims to achieve both impact and financial returns. It intends to take minority stakes in investee companies, with equity investments ranging from US$1 million to US$15 million ($1.4 million to 20.5 million) each.

Acromec inks LOI to establish private fertility centre with former customer's assets

SINGAPORE (June 6): Acromec has entered into a letter of intent (LOI) to collaborate on owning and operating a private fertility centre backed by a “leading US fertility centre” as a strategic investor and advisor.  

The project’s core management team will be led by two fertility medicine specialists who the company did not name.  

Assets required to operate the centre, such as its premises and equipment, will be acquired from a former customer of Acromec which has been placed under judicial management.

Clearbridge eyes more Chinese medical tourists with Hong Kong clinic expansion

SINGAPORE (June 4): Integrated healthcare company Clearbridge Health says it is planning to open a new 1,500 sq ft clinic along Causeway Bay, Hong Kong, to serve more domestic patients and medical tourists.

The new clinic will near-double the size of the existing 800 sq ft medical facility known as Clearbridge Medical Center, which is located along 555 Hennessy Road.

According to the company, its Hong Kong clinic served some 350 patients per month, of which the majority are medical tourists from China.

IHH Healthcare to see an exciting 2019 with increasingly palatable valuations: UOB

SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forward P/E of 57 times based on the stock’s performance on the KLSE.

Thomson Medical Group begins FY19 with million-dollar 1Q loss on higher finance costs

SINGAPORE (May 13): Thomson Medical Group (TMG), formerly known as Rowsley, has announced a $1 million loss for the 1Q ended March, reversing from earnings of $89,000 in 1Q18 due to a spike in finance costs in the recent quarter under review.

Revenue for 1Q19 grew 4% to $54.5 million from $52.5 million a year ago, due to higher inpatient volumes and higher average bill sizes at the Group’s hospitals and specialist clinics in Singapore and Malaysia.

Singapore O&G reports 15.5% earnings decline to $2.1 mil on higher operational expenses

SINGAPORE (May 9): Singapore O&G (SOG) has reported earnings of $2.1 million for 1Q19, down 15.5% from $2.5 million a year ago due to higher operational expenses.

This translates earnings per share (EPS) of 0.44 cent, down from 0.52 cent in 1Q18 although net asset value (NAV) per share grew to 9.79 cents as at end-March from 9.35 cents as at end-2018.

Revenue for the quarter grew 6.5% on-year to $8.7 million from $8.2 million previously as the group achieved revenue growth across its Obstetrics & Gynaecology (O&G), Cancer-related and Paediatrics segments.

Be informed of the stories that matter

Subscribe

Be informed of the stories that matter